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Comparison of a Low Osmolarity Nonionic Radiographic 
Contrast Agent With a Standard Medium on Renal 
Function in Cyanotic and Normal Dogs 
Ara K. Pridjian, MD, Edward L. Bove, MD, Robert H. Beekman 111, MD, 
and Flavian M. Lupinetti, MD 
Renal dysfunction may follow administration of iodinated radiographic contrast agents. 
This complication may be less common when low osmolarity nonionic agents are used. 
Although potential benefits from the use of low osmolarity nonionic contrast may be 
minimal in individuals with normal physiology, a greater benefit has been postulated in 
the presence of chronic cyanosis. To test this hypothesis, six adult mongrel dogs un- 
derwent anastomosis of the inferior vena cava to the left atrium. This produced chronic 
cyanosis with a mean PO, of 48 k 4 mm Hg and polycythemia with a mean hematocrit of 
56 2 2 gm%. Three to 5 months after preparation, these cyanotic dogs and five control 
dogs each received diatrizoate (a high osmolarity ionic agent) or ioversol (a low osmo- 
larity nonionic agent), 465 mg iodine/kg body weight, by intravenous bolus injection. One 
month later, each animal received the other agent. The order of administration was ran- 
domized. Renal function studies, including serum creatinine and creatinine clearance, 
were performed precontrast, after 60 min, and 24 hr postcontrast. Neither agent adversely 
affected renal function in either the cyanotic or the normal group. We conclude that at the 
doses that are commonly used in clinical practice, high osmolarity ionic contrast agents 
do not create a greater risk of renal injuiry than do low osmolarity nonionic agents in this 
model of cyanosis. 
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INTRODUCTION 
Infants with congenital heart disease are subjected to 
angiocardiography to define their cardiac anatomy. Re- 
nal dysfunction often develps in patients with cyanotic 
congenital heart disease [1,2] and these patients may be 
predisposed to renal injury from intravenous contrast 
agents. While low osmolarity nonionic agents are 
thought to produce less renal injury than high osmolarity 
ionic agents, the incidence of clinically important renal 
impairment following injection of either type of contrast 
agent is low. This low frequency makes it difficult to 
demonstrate any advantage to the use of expensive low 
osmolarity nonionic agents in a general population of 
patients undergoing angiography [3]. Patients with cy- 
anosis, however, are particularly at risk of renal cortical 
injury following contrast administration, possibly be- 
cause of polycythemia, oxygen desaturation, or intrinsic 
renal disease [4]. In cyanotic individuals, therefore, any 
advantage provided by a low osmolarity nonionic agent 
may be more pronounced. This study tested the hypoth- 
esis that low osmolarity nonionic contrast agents reduce 
the risk of renal dysfunction in the presence of chronic 
cyanosis in a canine model. 
MATERIALS AND METHODS 
Adult mongrel dogs that had been fasted overnight 
were anesthetized with sodium pentobarbitol, intubated, 
and mechanically ventilated. Cefazolin, 25 mg/kg, was 
given by intramuscular injection. All procedures were 
performed under sterile conditions in a veterinary oper- 
ating room. A right anterolateral thoracotomy was per- 
formed via the sixth intercostal space. Animals were he- 
parinized (100 mg/kg) and the inferior vena cava was 
divided and anastomosed to the left atrium in an end-to- 
side fashion using running 5-0 polypropelene. The tho- 
racotomy was closed and animals were allowed to re- 
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TABLE 1. Comparisons Between Normal and Cyanotic 
Animals (Mean values * standard error of the mean) 
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Normal Cvanotic 
cover for 3 to 5 months. At that time, the mean PO, 
among the dogs was 48 * 4 mm Hg and the mean hem- 
tocrit was 56 ? 2 gm%. 
Experimental observations were performed on six 
chronically cyanotic dogs and five control animals. An- 
imals were fasted on the day of the study but allowed 
water ad libitum. Animals received pentobarbitol anes- 
thesia and were intubated for mechanical ventilation. A 
Foley catheter was inserted into the bladder, a central 
venous catheter was passed into the internal jugular vein, 
and an arterial catheter was placed in the femoral artery 
for blood pressure monitoring and to obtain blood sam- 
ples. One hour urine collections were obtained for mea- 
surements of urine volume and creatinine content. Cre- 
atine clearance was calculated from the following 
formula: 
c,. = ucr x V/P,, 
where C, = creatinine clearance, U, = urinary cre- 
atine concentration, V = urine volume, and Pcr = 
plasma creatine concentration. A Kodak Ektachen DT60 
analyzer was used with a single slide system to determine 
serum and urine creatinine. 
Each animal then received diatrizoate (a high osmo- 
larity ionic agent) or ioversol (a low osmolarity nonionic 
agent), 465 mg iodinelkg body weight by intravenous 
bolus injection. Blood and urine samples were then ob- 
tained 1 hour after contrast administration. All instru- 
mentation was removed, and the animals were allowed to 
awaken and return to their cages, where food and water 
were provided ad libitum. One additional blood sample 
was obtained 24 hours after administration of the contrast 
medium for measurement of serum creatinine. One 
month later, each animal underwent the same procedure 
but with administration of the other contrast medium. 
The order of contrast administration was randomized. 
Group means and standard errors were calculated for 
each group of dogs receiving each contrast agent. Sta- 
tistical analysis was performed using paired Student’s t 
test to compare differences in response to the contrast 
agents within groups and unpaired Student’s t test to 
compare the cyanotic and normal groups. Differences 
were considered statistically significant at a p value < 
.05. 
Animals received humane care in compliance with the 
“Principles of Laboratory Animal Care” formulated by 
the National Society for Medical Research and the 
“Guide for the Care and Use of Laboratory Animals” 
prepared by the Institute of Laboratory Animal Re- 
sources and published by the National Institutes of 
Health (NIH Publication No. 86-23, revised 1985). 
Weight (kg) 4 4 ? 3  43 2 2 
Po, (mm Hg) 85 2 5 48 It 4* 
Hematocrit (W) 34 2 2 56 2 2* 
Baseline serum creatinine (mg/dl) 0.76 ? 0.05 0.78 2 0.15 
Baseline creatinine clearance (mllmin) 46 2 10 43 2 3 
* p  < .05 compared to normal group. 
RESULTS 
Comparisons between the cyanotic and acyanotic an- 
imals are shown in Table I. Cyanotic animals were sig- 
nificantly different from control animals with respect to 
p0, and hematocrit. Renal function was similar, how- 
ever. Responses to contrast administration are illustrated 
in Figures 1 and 2. Serum creatinine fell significantly in 
the cyanotic group 1 hour after the administration of 
either contrast agent. By 24 hr after contrast, serum cre- 
atinine returned to baseline levels. Creatinine cleareance 
1 hour after injection of either agent did not decrease in 
the cyanotic or in the control group. 
DISCUSSION 
Conventional high osmolarity ionic contrast media are 
composed of organic molecules of triiodobenzoic acid. 
Each molecule contains three iodine atoms and dissoci- 
ates into two osmotically active particles in solution. The 
typical osmolarity range is from 1,400 to 2,400 mOsm/l. 
Low osmolarity nonionic agents also have three atoms of 
iodine per molecule, but they do not dissociate. The 
osmolarity of these agents is 400-850 mOsm/l, or about 
one-third of the high osmolarity ionic agents [ 5 ] .  Low 
osmolarity nonionic agents are well tolerated, less pain- 
ful, and produce equal density on angiograms compared 
to ionic agents. Low osmolarity nonionic agents, how- 
ever, are more expensive than high osmolarity ionic me- 
dia. It has been estimated that the increased incremental 
cost of low osmolarity nonionic agents is $100-200 per 
catheterization. In the United States, approximately 
l,OOO,OOO procedures are performed annually. Thus, the 
uniform use of low osmolarity nonionic contrast would 
add $100,000,000 to $200,000,000 to the nation’s health 
care costs (61. 
Adverse effects of contrast media include pulmonary 
edema, consumption coagulopathy , myocardial ischemia 
and infarction, ventricular anytrhmias, bradycardia and 
asystolic cardiac arrest, cerebral edema and convulsions, 
glottic edema with airway obstruction, laryngeal spasm, 
spinal cord necrosis, and renal cortical necrosis [6,7]. 
Renal insufficiency may also occur after contrast admin- 
istration. Factors that may be important in predicting 
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Fig. 1. Serum creatinine before and after contrast injection in 
control and cyanotic animals. Serum creatinine was decreased 
in cyanotic animals 1 hr postcontrast with either contrast agent, 
and returned to baseline by 24 hr (*p < .05 vs. precontrast con- 
trol). 
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Fig. 2. Creatinine clearance before and after contrast injection 
in control and cyanotic animals. Creatinine clearance did not 
decrease in cyanotic or normal dogs after receiving either ionic 
or nonionic agents. 
renal insufficiency after contrast administration include 
diabetes, multiple myeloma, volume depletion, and pre- 
existing renal insufficiency [8,9]. In such individuals 
there is up to a 30% risk of an increase in serum creat- 
inine of more than 20%. Without these risk factors, how- 
ever, renal dysfunction occurs in only 2% of patients and 
is usually transient [lo]. 
Few clinical or laboratory studies have been per- 
formed to identify and stratify contrast-related risks in 
patients undergoing angiography for congenital cardiac 
disease. Sagy and associates [lo] studied two groups of 
patients with congenital heart disease to determine the 
response to contrast agents. One group of patients had a 
preponderance of left ventricular volume overload, 
which were mostly due to ventricular septa1 defects or 
other left-to-right shunt lesions. The other group con- 
sisted of patients with obstruction to right ventricular 
outflow, such as pulmonary stenosis or tetralogy of Fal- 
lot. The left ventricular volume overload group exhibited 
a significant elevation of serum creaatinine and uric acid 
in the first 24 hours after contrast injection. This renal 
impairment appeared to be related to age, with patients 
older than 5 years exhibiting the greatest rise in creati- 
nine [ 111. 
Effective precautions to reduce the frequency and se- 
verity of contrast-induced renal insufficiency remain a 
desirable objective. If it could be demonstrated that low 
osmolarity nonionic contrast agents were efficacious in 
this regard, even in a selected group of patients, a stron- 
ger argument could be made for their application. Al- 
though low osmolarity nonionic media have theoretical 
advantages in reducing adverse effects, most clinical tri- 
als have not supported their use [3,12-151. In a retro- 
spective analysis of patients at high risk for renal insuf- 
ficiency because of preexisting kidney disease, 
administration of low osmolarity medium was associated 
with a 15% incidence of further renal impairment, and 
the resulting nephropathy correlated significantly with 
the amount of contrast that was administered [ 161. The 
dose of contrast medium administered in this study was 
equivalent to a 2 ml/kg bolus, within the 1-3 mVkg range 
of contrast dosing currently used at this institution. 
Some clinical studies, however, have found some ben- 
efits of low osmolar nonionic media. Gertz and associ- 
ates found iopamidol, a low osmolar nonionic agent, to 
be associated with less nausea and vomiting, allergic 
reaction, and adverse effects of all types compared with 
ioxaglate, a high osmolar ionic contrast [17]. The study 
reported by Jenvnikar and colleagues found low osmo- 
larity nonionic solutions to be associated with a de- 
creased risk of renal impairment as assessed by sensitive 
measurement of urinary tubular enzyme excretion. In 
this study, however, glomerular filtration rate was not 
affected, so the clinical importance of the enzymuria was 
judged to be uncertain [4]. 
Because the additional expense may not justify the 
routine administration of low osmolarity nonionic agents 
to all patients, identification of patients at a particularly 
high risk for contrast-related complications may lead to 
more rational use. Cyanotic patients may represent such 
a high risk group. Adults with cyanotic congenital heart 
defects have urinary abnormalities consistent with glom- 
erulopathy in as many as a third of cases [4]. Renal 
insufficiency associated with cyanosis correlates with the 
degree of polycythemia [l] as well as the duration of 
cyanosis [2]. Evaluation of the renal effects of contrast 
media is therefore warranted in this group of patients. 
The small number of animals used in this study may limit 
the ability of this investigation to discern subtle differ- 
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ences. The absence of any detectable renal impairment, 
however, at contrast doses consistent with those used in 
typical angiographic examinations does not support the 
use of low osmolarity nonionic media in the presence of 
chronic cyanosis. This study examined only one of the 
multiple risks of contrast administration, and it remains 
possible that low osmolarity nonionic media do provide 
some degree of protection against hemodynamic compli- 
cations in cyanotic individuals. 
Although there seem to be fewer adverse effects of 
nonionic than ionic agents, large clinical trials do not 
conclusively show their advantage. Because of the addi- 
tional expense of nonionic agents, it may become diffi- 
cult to justify their use in all patients, and it may become 
necessary to select patients who are at highest risk and 
would benefit most from use of nonionic agents [7,8]. 
While this study involves only a small number of animals 
and does not address other adverse effects, it suggests 
that patients with cyanotic congenital heart disease and 
polycythemia are not necessarily at high risk for devel- 
oping acute renal failure when receiving ionic contrast 
agents. 
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